Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about EuMentis Therapeutics aggregated by PharmaCompass.com.

    Client Virtual Booth

    EUMENTIS THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    EuMentis Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    508 Dudley Rd # 105 Newton, MA, 02459-2809
    Telephone
    Telephone
    (617) 413-3020
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.eumentistx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eumentis-therapeutics-inc
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    EuMentis Announces the First Closing of a Targeted $40M Series B Financing
    EuMentis Announces the First Closing of a Targeted $40M Series B Financing

    https://www.globenewswire.com/news-release/2023/02/15/2608538/0/en/EuMentis-Therapeutics-Inc-Announces-the-First-Closing-of-a-Targeted-40M-Series-B-Financing-to-Advance-Novel-Therapeutics-to-Treat-Autism-Spectrum-Disorder-Tourette-Syndrome-and-Tra.html

    GLOBENEWSWIRE
    15 Feb 2023
    Share Share
    ImmunityBio, Codagenix and EuMentis raise funds, while a biotech SPAC dissolves
    ImmunityBio, Codagenix and EuMentis raise funds, while a biotech SPAC dissolves

    https://endpts.com/immunitybio-codagenix-and-eumentis-raise-funds-while-a-biotech-spac-dissolves/

    Kyle LaHucik ENDPTS
    15 Feb 2023
    Share Share
    EuMentis Receives $3M Award from US DoD to Advance NMDA Receptor Antagonist
    EuMentis Receives $3M Award from US DoD to Advance NMDA Receptor Antagonist

    https://www.globenewswire.com/news-release/2023/02/08/2603783/0/en/EuMentis-Therapeutics-Inc-Receives-3-Million-Award-from-United-States-Department-of-Defense-DoD-to-Advance-its-Novel-NMDA-Receptor-Antagonist-for-Traumatic-Brain-Injury.html

    GLOBENEWSWIRE
    08 Feb 2023
    Share Share
    Biotech receives award from DOD; Regulators accept Appili Therapeutics' NDA
    Biotech receives award from DOD; Regulators accept Appili Therapeutics' NDA

    https://endpts.com/biotech-receives-award-from-dod-regulators-accept-appili-therapeutics-nda/

    ENDPTS
    08 Feb 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search